Epstein Secrets

and Eli Lilly EUAs, "a designation that would make the medicines more broadly available. But the companies said they have submitted the requests to the Food and Drug Administration — a process that the agency has repeatedly tried to assure the public is based on science and free of political interference." Experts "said that by

r future living standards and a longer, slower road back to prosperity." Stocks Post Gains Amid Hope For Stimulus Deal. The AP (10/8, Choe, Troise, Veiga) reports stocks finished higher "for the second day in a row Thursday, reflecting hope on Wall Street that Washington can approve more aid for the

finally dispatch what are known as landing teams to the Department of Health and Human Services, the Centers for Disease Control and Prevention and the Food and Drug Administration." The New York Times (11/24, Wolfe, 18.61M) reports Biden's landing teams for the FDA "will need to get up to speed on a planned vaccine rollout, a

expected to nominate former Fed chief Janet Yellen for Treasury Secretary, proving President Trump's pre-election predictions wrong." The AP (11/24, Veiga, Troise) similarly says investors "were encouraged by the latest progress on developing coronavirus vaccines and news that the transition of power

and Eli Lilly EUAs, "a designation that would make the medicines more broadly available. But the companies said they have submitted the requests to the Food and Drug Administration — a process that the agency has repeatedly tried to assure the public is based on science and free of political interference." Experts "said that by

r future living standards and a longer, slower road back to prosperity." Stocks Post Gains Amid Hope For Stimulus Deal. The AP (10/8, Choe, Troise, Veiga) reports stocks finished higher "for the second day in a row Thursday, reflecting hope on Wall Street that Washington can approve more aid for the